Kolexia
Megraud Francis
Biologie médicale
Hôpital Pellegrin
Bordeaux, France
284 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Infections à Helicobacter Tumeurs de l'estomac Infections à Campylobacter Lymphome B de la zone marginale Inflammation Maladies transmissibles Entorses et foulures Gastrite Lymphomes

Industries

Biocodex
3 collaboration(s)
Dernière en 2022
Sanofi
1 collaboration(s)
Dernière en 2023
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Sequential versus Standard Triple Therapy for First-Line Eradication: An Update.
Antibiotics (Basel, Switzerland)   30 janvier 2024
Association between Helicobacter pylori infection and incident risk of dementia: The AMI cohort.
Journal of the American Geriatrics Society   23 janvier 2024
Helicobacter pylori Infection and Pathogenic Variants in Homologous Recombination Genes in Gastric Cancer.
Clinical chemistry   05 janvier 2024
Global prevalence of Helicobacter pylori infection and incidence of gastric cancer between 1980 and 2022.
Gastroenterology   02 janvier 2024
Role of proton pump inhibitors dosage and duration in Helicobacter pylori eradication treatment: Results from the European Registry on H. pylori management.
United European gastroenterology journal   04 décembre 2023
Effectiveness of Helicobacter pylori treatments according to antibiotic resistance.
The American journal of gastroenterology   17 novembre 2023
Author Correction: Comparison of the management of Helicobacter pylori infection between the older and younger European populations.
Scientific reports   01 novembre 2023
Comparison of the management of Helicobacter pylori infection between the older and younger European populations.
Scientific reports   11 octobre 2023
Analysis of Clinical Phenotypes through Machine Learning of First-Line Treatment in Europe during the Period 2013-2022: Data from the European Registry on Management (Hp-EuReg).
Antibiotics (Basel, Switzerland)   10 septembre 2023
Bismuth quadruple three-in-one single capsule three times a day increases effectiveness compared with the usual four times a day schedule: results from the European Registry on Management (Hp-EuReg).
Gut   19 juillet 2023